Gene · 1815
Papers4,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305. | Front Pharmacol | 2022 | 36756144 | PubTator, text mining | PubMed |
| The Role of Sex in Genetic Association Studies of Depression. | J Psychiatr Brain Sci | 2022 | 36741030 | PubTator, text mining | PubMed |
| DNA methylation signature of psychological resilience in young adults: Constructing a methylation risk score using a machine learning method. | Front Genet | 2022 | 36712885 | PubTator, text mining | PubMed |
| Editorial: The heterogeneity of neuropsychiatric disorders. | Front Psychiatry | 2022 | 36704732 | PubTator, text mining | PubMed |
| Identification of ferroptosis-related genes and predicted overall survival in patients with burns. | Front Surg | 2022 | 36700031 | PubTator, text mining | PubMed |
| Emotional Intelligence in Carriers of Different СОМТ, BDNF, DRD2 and HTR2A Genotypes. | Psychol Russ | 2022 | 36699706 | PubTator, text mining | PubMed |
| The sexual selection of creativity: A nomological approach. | Front Psychol | 2022 | 36698589 | PubTator, text mining | PubMed |
| Differences in MB-COMT DNA methylation in monozygotic twins on phenotypic indicators of impulsivity. | Front Genet | 2022 | 36685886 | PubTator, text mining | PubMed |
| Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder. | Front Neurosci | 2022 | 36685234 | PubTator, text mining | PubMed |
| Short-term exposure to fine particulate matter and genome-wide DNA methylation in chronic obstructive pulmonary disease: A panel study conducted in Beijing, China. | Front Public Health | 2022 | 36684947 | PubTator, text mining | PubMed |
| Prevalence of Common Alleles of Some Stress Resilience Genes among Adolescents Born in Different Periods Relative to the Socioeconomic Crisis of the 1990s in Russia. | Curr Issues Mol Biol | 2022 | 36661490 | PubTator, text mining | PubMed |
| Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells. | Cancers (Basel) | 2022 | 36612109 | PubTator, text mining | PubMed |
| Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia. | Psychol Res Behav Manag | 2022 | 36605176 | PubTator, text mining | PubMed |
| Volleying plasma membrane proteins from birth to death: Role of J-domain proteins. | Front Mol Biosci | 2022 | 36589230 | PubTator, text mining | PubMed |
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family. | J Pers Med | 2022 | 36579592 | PubTator, text mining | PubMed |
| Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index. | J Pers Med | 2022 | 36579510 | PubTator, text mining | PubMed |
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. | J Pers Med | 2022 | 36556236 | PubTator, text mining | PubMed |
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. | J Pers Med | 2022 | 36556167 | PubTator, text mining | PubMed |
| A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years. | Int J Mol Sci | 2022 | 36555602 | PubTator, text mining | PubMed |
| Exploration of restless legs syndrome under the new concept: A review. | Medicine (Baltimore) | 2022 | 36550837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1815/papers?page=18